K
Karen R. Cleary
Researcher at University of Texas MD Anderson Cancer Center
Publications - 158
Citations - 20952
Karen R. Cleary is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Adenocarcinoma & Metastasis. The author has an hindex of 67, co-authored 158 publications receiving 20453 citations. Previous affiliations of Karen R. Cleary include University of Texas Health Science Center at Houston & University of Florida.
Papers
More filters
Journal Article
Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma
James C. Cusack,Geoffrey G. Giacco,Karen R. Cleary,B. Scott Davidson,Francesco Izzo,John M. Skibber,Julia Yen,Steven A. Curley +7 more
TL;DR: An increased incidence of three biological indicators of aggressive and potentially metastatic tumor biology in 186 young patients with carcinoma of the colon and rectum: signet-ring cell carcinoma, infiltrating tumor edges, and aggressive histologic grade in the primary adenocarcinoma is demonstrated.
Journal ArticleDOI
Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study.
TL;DR: It is indicated that the basaloid cells of BCH, ABT, and ACC are derived from basal cells of the normal prostate gland and suggest a continuum among the three lesions.
Journal ArticleDOI
Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer.
Timothy M. Pawlik,Eddie K. Abdalla,Carlton C. Barnett,Syed A. Ahmad,Karen R. Cleary,Jean Nicolas Vauthey,Jeffrey E. Lee,Douglas B. Evans,Peter W.T. Pisters,Fabrizio Michelassi,Michael B. Farnell,Margaret Shoup,Clive S. Grant +12 more
TL;DR: In this paper, the authors proposed a biostatistical model with the following assumptions: extended lymphadenectomy can benefit only patients who actually have disease removed from second-echelon nodes, have microscopically negative (R0) primary tumor resection margins, and do not have visceral metastatic (M0) disease.
Journal Article
Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion: role of sialyl-LeX antigens.
Tatsuro Irimura,S Nakamori,Yoshifumi Matsushita,Taniuchi Y,N Todoroki,Tsuji T,Izumi Y,Y. Kawamura,S. D. Hoff,Karen R. Cleary +9 more
TL;DR: It is concluded that sialyl-LeX carbohydrate antigen is a unique molecular phenotype that determines colorectal cancer metastasis.
Journal Article
Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer
Yutaka Takahashi,Corazon D. Bucana,Yoshito Akagi,Wenbiao Liu,Karen R. Cleary,Masayoshi Mai,Lee M. Ellis +6 more
TL;DR: An association between PD-ECGF expression in infiltrating cells, VEGF expression in tumor epithelium, and vessel count was observed in intestinal-type Gastric cancer but not in diffuse-type gastric cancer.